Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 59 min ago
Peer-reviewedCC BY-NC-ND 4.0Liver Transplantation

Evaluation of available scoring systems in liver transplantation for severe acute-on-chronic liver failure (ACLF)

12 more authors

Abstract

Background & aims: The Transplantation for ACLF-3 Model (TAM) and Sundaram ACLF-LT-Mortality score (SALT-M) have been proposed to help select liver transplantation (LT) candidates with Acute-on-Chronic Liver Failure (ACLF) to optimize post-LT outcomes. We assessed the performance and clinical utility of these scores and their components on a large retrospective international multicenter study. Approach & results: All patients transplanted in the context of ACLF grade 3 (n=336) from nine international cohorts (2008-2024) were included in the study. The primary endpoint was 1-year post-LT survival. Score discrimination, calibration, and clinical utility using decision-curve (net benefit) analysis were assessed. The 1-year post-LT survival rate was 75.3%. Both TAM (OR 1.91, p=0.0001) and SALT-M (OR 1.09, p<0.0001) were associated with 1-year mortality but showed only modest discriminative performance (AUROC 0.61 and 0.64, respectively). Clinically relevant candidate high-risk thresholds were identified: TAM ≥3 (1-year survival 42.9% vs. 79.0%) and SALT-M >25 (46.9% vs. 78.7%). Respiratory failure (PaO₂/FiO₂ ≤200) was associated with 1-year post-LT mortality, whereas other variables included in the original scores, diabetes, BMI, and leukocyte count, did not demonstrate significant prognostic value in this cohort. Conclusions: In this large multicenter study, TAM and SALT-M were associated with post-LT mortality but demonstrated limited discriminative accuracy. Candidate high-risk thresholds (TAM ≥3, SALT-M >25) may help identify a small subset of patients with markedly poor post-LT outcomes. However, given their modest performance, these scores should support, not replace, multidisciplinary decision-making and their applicability should be evaluated in a prospective fashion.

Related

  1. Prognostic value of chronic total occlusion complexity scoring systems beyond procedural planning: a comparative analysis of five contemporary scores in patients undergoing chronic total occlusion percutaneous coronary intervention
    Mehmet K. Teber, Mehmet Z. Aydın
    Postepy w kardiologii interwencyjnej = Advances in interventional cardiologyPeer-reviewedCC BY-NC-SAFull textSurgery & anaesthesiaEurope PMCPMC
  2. Comparative Evaluation of Prognostic Scoring Systems for Metastatic Spinal Tumors: Utility of the New Katagiri and Skeletal Oncology Research Group Models
    Junya Miyahara, Kazuki Abe, Rie Kodama +5
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaCrossrefEurope PMC
  3. Comparative Quality Evaluation of Marketed Cefixime Trihydrate Tablet Brands Available in Bangladesh
    Ariful Islam, Shahriar Alam Shanto, Sumaiya Akter +6
    The Scientific World JournalPeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMC
  4. Prognostic value of scoring systems in geriatric patients receiving warfarin presenting with upper gastrointestinal bleeding
    Tufan Akin Giray, Ramazan Guven, Akkan Avci +22
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  5. Comparative Evaluation of Two Commercially Available Topical Gels As Adjuncts to Scaling and Root Planing for Gingival Inflammation: A Randomized Controlled Trial.
    Abhishek Sharma, Ajay Mahajan, Kanwarjit Singh Asi
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{lhermite2026evaluation,
  title = {{Evaluation of available scoring systems in liver transplantation for severe acute-on-chronic liver failure (ACLF)}},
  author = {Sébastien L’hermite and Isaure Breteau and Sebastien Halter and Nicolas Jacquinot and Valentin Coirier and José Ursic-Bedoya and Giovanni Perricone and Laure Elkrief and Philippe Ichai and Audrey Coilly and Sophie-Caroline Sacleux and Pauline Houssel‐debry and Baptiste Giguet and Line Carolle Ntandja Wandji and Alexandre Louvet and Filomena Conti and Edouard Bardou-Jacquet and Georges-Philippe Pageaux and Antoine Monsel and Eric Levesque and Constantine J. Karvellas and Jean-François Morcet and William Bernal and Florent Artru},
  journal = {Liver Transplantation},
  year = {2026},
  month = sep,
  doi = {10.1097/lvt.0000000000000987},
  url = {https://hal.science/hal-05754643v1},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Evaluation of available scoring systems in liver transplantation for severe acute-on-chronic liver failure (ACLF)
AU  - Sébastien L’hermite
AU  - Isaure Breteau
AU  - Sebastien Halter
AU  - Nicolas Jacquinot
AU  - Valentin Coirier
AU  - José Ursic-Bedoya
AU  - Giovanni Perricone
AU  - Laure Elkrief
AU  - Philippe Ichai
AU  - Audrey Coilly
AU  - Sophie-Caroline Sacleux
AU  - Pauline Houssel‐debry
AU  - Baptiste Giguet
AU  - Line Carolle Ntandja Wandji
AU  - Alexandre Louvet
AU  - Filomena Conti
AU  - Edouard Bardou-Jacquet
AU  - Georges-Philippe Pageaux
AU  - Antoine Monsel
AU  - Eric Levesque
AU  - Constantine J. Karvellas
AU  - Jean-François Morcet
AU  - William Bernal
AU  - Florent Artru
PY  - 2026
DA  - 2026/09/08
JO  - Liver Transplantation
DO  - 10.1097/lvt.0000000000000987
UR  - https://hal.science/hal-05754643v1
AB  - Background & aims: The Transplantation for ACLF-3 Model (TAM) and Sundaram ACLF-LT-Mortality score (SALT-M) have been proposed to help select liver transplantation (LT) candidates with Acute-on-Chronic Liver Failure (ACLF) to optimize post-LT outcomes. We assessed the performance and clinical utility of these scores and their components on a large retrospective international multicenter study. Approach & results: All patients transplanted in the context of ACLF grade 3 (n=336) from nine international cohorts (2008-2024) were included in the study. The primary endpoint was 1-year post-LT survival. Score discrimination, calibration, and clinical utility using decision-curve (net benefit) analysis were assessed. The 1-year post-LT survival rate was 75.3%. Both TAM (OR 1.91, p=0.0001) and SALT-M (OR 1.09, p<0.0001) were associated with 1-year mortality but showed only modest discriminative performance (AUROC 0.61 and 0.64, respectively). Clinically relevant candidate high-risk thresholds were identified: TAM ≥3 (1-year survival 42.9% vs. 79.0%) and SALT-M >25 (46.9% vs. 78.7%). Respiratory failure (PaO₂/FiO₂ ≤200) was associated with 1-year post-LT mortality, whereas other variables included in the original scores, diabetes, BMI, and leukocyte count, did not demonstrate significant prognostic value in this cohort. Conclusions: In this large multicenter study, TAM and SALT-M were associated with post-LT mortality but demonstrated limited discriminative accuracy. Candidate high-risk thresholds (TAM ≥3, SALT-M >25) may help identify a small subset of patients with markedly poor post-LT outcomes. However, given their modest performance, these scores should support, not replace, multidisciplinary decision-making and their applicability should be evaluated in a prospective fashion.
SN  - 1527-6465
SN  - 1527-6473
ER  -